HomeCompareKSRBF vs MRK

KSRBF vs MRK: Dividend Comparison 2026

KSRBF yields 3.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.6K in total portfolio value
10 years
KSRBF
KSRBF
● Live price
3.00%
Share price
$0.33
Annual div
$0.01
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.2K
Annual income
$0.30
Full KSRBF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KSRBF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKSRBFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KSRBF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KSRBF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KSRBF
Annual income on $10K today (after 15% tax)
$255.33/yr
After 10yr DRIP, annual income (after tax)
$0.26/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,328.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KSRBF + MRK for your $10,000?

KSRBF: 50%MRK: 50%
100% MRK50/50100% KSRBF
Portfolio after 10yr
$38.5K
Annual income
$4,899.22/yr
Blended yield
12.73%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KSRBF
No analyst data
Altman Z
8.0
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KSRBF buys
0
MRK buys
0
No recent congressional trades found for KSRBF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKSRBFMRK
Forward yield3.00%2.76%
Annual dividend / share$0.01$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$20.2K$56.8K
Annual income after 10y$0.30$9,798.13
Total dividends collected$303.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KSRBF vs MRK ($10,000, DRIP)

YearKSRBF PortfolioKSRBF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,850$150.20$11,206$366.19$356.00MRK
2$11,686$76.15$12,650$502.35$964.00MRK
3$12,542$38.33$14,407$694.19$1.9KMRK
4$13,439$19.22$16,585$967.82$3.1KMRK
5$14,390$9.62$19,342$1,363.89$5.0KMRK
6$15,402$4.82$22,913$1,947.19$7.5KMRK
7$16,482$2.41$27,662$2,823.89$11.2KMRK
8$17,637$1.20$34,159$4,173.35$16.5KMRK
9$18,873$0.60$43,337$6,308.80$24.5KMRK
10$20,194$0.30$56,776$9,798.13$36.6KMRK

KSRBF vs MRK: Complete Analysis 2026

KSRBFStock

Kossan Rubber Industries Bhd, an investment holding company, manufactures and sells latex disposable gloves in Malaysia and internationally. It operates through four segments: Technical Rubber Products, Gloves, Cleanroom Products, and Others. The company offers engineered rubber products, including marine dock fenders, high damping rubber bearings, elastomeric bearings, expansion joints, panels and liners, and mechanical pot bearings, as well as floating slab track bearings, lateral bearings, and rubber wedges; EVA products primarily for the shoe industries; and custom extruded products and profiles, such as pressure sensor, solid and sponge, extruded, structural insulation, and insulator profiles for domestic, construction and civil engineering, electrical appliance, industrial, and automotive applications. It also provides molded rubber products for automotive, pipe seals and gaskets, and industrial/general applications; rubber rolls for printing, transferring, laminating, coating, coiling, beading creasing, pressure, slitting, winding, and other applications; and polyurethane (PU) products, such as PU rollers, precision PU articles, and PU tubing sleeves and robs. In addition, it manufactures natural rubber latex and nitrile gloves, as well as rubber latex surgical and procedure gloves for healthcare, specialty, and cleanroom applications under Puresafe, Chemax, and 7th Sense brand names. Further, the company offers cleanroom facemasks, gloves, and wipes; and industrial personal protective equipment. Additionally, it engages in the fabrication and installation of machinery; manufacturing, processing, and trading of chemicals and rubber compounds; and distribution and property holding activities. The company was incorporated in 1979 and is based in Klang, Malaysia.

Full KSRBF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KSRBF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KSRBF vs SCHDKSRBF vs JEPIKSRBF vs OKSRBF vs KOKSRBF vs MAINKSRBF vs JNJKSRBF vs ABBVKSRBF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.